netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:
Please also refer to the Cancer Drugs Fund list

08.01 Cytotoxic drugs
Side-effects of cytotoxic drugs
Drugs for cytotoxic-induced side-effects
08.01.01 Alkylating drugs
08.01.02 Anthracyclines and other cytotoxic antibiotics
08.01.03 Antimetabolites
08.01.04 Vinca alkaloids and etoposide
08.01.05 Other antineoplastic drugs
Amsacrine
Bevacizumab
Bexarotene
Bortezomib
Cetuximab
Crisantaspase
Dacarbazine and Temozolomide
Erlotinib
Hydroxycarbamide
Imatinab
Ipilimumab
Mitotane
Pentostatin
Platinum compounds
Procarbazine
Protein kinase inhibitors
Taxanes
Topoisomerase I inhibitors
Trabectedin
Trastuzumab
Tretinoin
08.02 Drugs affecting the immune response
08.02.01 Antiproliferative immunosuppressants
08.02.02 Corticosteroids and other immunosuppressants
08.02.03 Anti-lymphocyte monoclonal antibodies
08.02.04 Other immunomodulating drugs
Interferon Alfa
Interferon beta
Aldesleukin
Glatiramer acetate
Natalizumab
08.03 Sex hormones and hormone antagonists in malignant disease
08.03.01 Oestrogens
08.03.02 Progestogens
08.03.03 Androgens
08.03.04 Hormone antagonists
08.03.04.01 Breast cancer
08.03.04.02 Prostate cancer and gonadorelin analogues
Gonadorelin analogues
Anti-androgens
08.03.04.03 Somatostatin analogues
08.04 Miscellaneous preparations
netFormulary